← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 6, 2018Last known activity
Apr 24, 2023
Acquired by AbbVie on Mar 25, 2024
Timeline
2010s
- Jan 1, 2017
Landos Biopharma Inc.— Founded
2020s
- Mar 25, 2024
AbbVie— Acquired By
Drugs by trial phase (4 distinct, 9 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT05785715Lead sponsorPhase 2Apr 24, 2023
- NCT05785715Overall official - principal investigatorPhase 2Apr 24, 2023
- NCT04835168Study directorPhase 1Jan 30, 2022
- NCT04835168Lead sponsorPhase 1Jan 30, 2022
- NCT05057273Lead sponsorPhase 2Nov 30, 2021
- NCT05057273Study directorPhase 2Nov 30, 2021
- NCT05019950Study directorPhase 1Oct 28, 2021
- NCT05019950Lead sponsorPhase 1Oct 28, 2021
- NCT04862741Study directorPhase 1May 5, 2021
- NCT04862741Lead sponsorPhase 1May 5, 2021
- NCT04458805Lead sponsorPhase 1Jul 10, 2020
- NCT04458805Study directorPhase 1Jul 10, 2020
- NCT03870334Study directorPhase 2Mar 31, 2019
- NCT03861143Lead sponsorPhase 2Mar 31, 2019
- NCT03861143Study directorPhase 2Mar 31, 2019
Details
- Founded
- Blacksburg, VA, US Jan 1, 2017
- Last known activity
- Apr 24, 2023